All Title Author
Keywords Abstract

Publish in OALib Journal
ISSN: 2333-9721
APC: Only $99


Comparison of Quality of Life, Depression and Anxiety According to the Type of Treatment in Type 2 Diabetes

DOI: 10.4236/oalib.1110062, PP. 1-9

Subject Areas: Epidemiology, Diabetes & Endocrinology

Keywords: Diabetes Type 2, Type of Treatment, Insulin, Depression, Anxiety, Quality of Life

Full-Text   Cite this paper   Add to My Lib


The aim of this study was to compare the quality of life (QoL) and the prevalence of depression and anxiety in patients with type 2 diabetes mellitus according to the type of treatment: insulin, oral therapy or both therapies. A cross-sectional study that included adults with diabetes mellitus type 2 was conducted at Hassan II University Hospital in Fez, Morocco. Patients are divided into 3 groups: the anti-diabetic agents’ group, the insulin therapy group and the combined therapy group. The Hospital Anxiety and Depression Scale (HADS) was used to measure depression and anxiety. A 12-Item Short-Form Health Survey questionnaire (SF-12) was employed to assess QoL. All statistical analyses were conducted using SPSS Version 26. A total of 176 diabetics with type 2 were included in the study: (61.9%) in the hypoglycemic drug group; (14.2%) in the insulin group and (23.9%) in both therapy groups. The mean age of the patients was 54.36 ± 10.18 years with a female predominance (60.8%). Our study showed a significant association between the scores of QoL (p < 0.05), the prevalence of depression (p = 0.03) and the type of therapy. A high prevalence of depression and poor QoL have been observed in patients on insulin therapy. Patients on insulin therapy have a high prevalence of depression and a more significant impairment of QoL. In fact, their evaluation must be integrated into the management of type 2 diabetics on insulin.

Cite this paper

Benmaamar, S. , Salhi, H. , Harch, I. E. , Lazar, N. , Diagne, B. J. , Maiouak, M. , Berraho, M. , Tachfouti, N. , Ouahabi, H. E. and Fakir, S. E. (2023). Comparison of Quality of Life, Depression and Anxiety According to the Type of Treatment in Type 2 Diabetes. Open Access Library Journal, 10, e062. doi:


[1]  Saeedi, P., Petersohn, I., Salpea, P., et al. (2019) Global and Regional Diabetes Prevalence Estimates for 2019 and Projections for 2030 and 2045: Results from the International Diabetes Federation Diabetes Atlas, 9th Edition. Diabetes Research and Clinical Practice, 157, Article ID: 107843.
[2]  Khan, M.A.B., Hashim, M.J., King, J.K., Govender, R.D., Mustafa, H. and Al Kaabi, J. (2019) Epidemiology of Type 2 Diabetes—Global Burden of Disease and Forecasted Trends. Journal of Epidemiology and Global Health, 10, 107-111.
[3]  Rapport Annuel Global de l’AMO 2018.
[4]  Rapport de l’enquête nationale sur les facteurs de risque des maladies non transmissibles 2017-2018.
[5]  Bickett, A. and Tapp, H. (2016) Anxiety and Diabetes: Innovative Approaches to Management in Primary Care. Experimental Biology and Medicine (Maywood), 241, 1724-1731.
[6]  Roy, T. and Lloyd, C.E. (2012) Epidemiology of Depression and Diabetes: A Systematic Review. Journal of Affective Disorders, 142, S8-S21.
[7]  Jing, X., Chen, J., Dong, Y., et al. (2018) Related Factors of Quality of Life of Type 2 Diabetes Patients: A Systematic Review and Meta-Analysis. Health and Quality of Life Outcomes, 16, 189.
[8]  Shetty, A., Afroz, A., Ali, L., Siddiquea, B.N., Sumanta, M. and Billah, B. (2021) Health-Related Quality of Life among People with Type 2 Diabetes Mellitus—A Multicentre Study in Bangladesh. Diabetes & Metabolic Syndrome: Clinical Research & Reviews, 15, Article ID: 102255.
[9]  Chung, J.O., Cho, D.H., Chung, D.J. and Chung, M.Y. (2013) Assessment of Factors Associated with the Quality of Life in Korean Type 2 Diabetic Patients. Internal Medicine, 52, 179-185.
[10]  Cong, J.-Y., Zhao, Y., Xu, Q.-Y., et al. (2012) Health-Related Quality of Life among Tianjin Chinese Patients with Type 2 Diabetes: A Cross-Sectional Survey. Nursing & Health Sciences, 14, 528-534.
[11]  Marín-Peñalver, J.J., Martín-Timón, I., Sevillano-Collantes, C. and Cañizo-Gómez, F.J. (2016) Del: Update on the Treatment of Type 2 Diabetes Mellitus. World Journal of Diabetes, 7, 354.
[12]  Bai, X., Liu, Z., Li, Z. and Yan, D. (2018) The Association between Insulin Therapy and Depression in Patients with Type 2 Diabetes Mellitus: A Meta-Analysis. BMJ Open, 8, e020062.
[13]  Surkiene, G. (2014) Prevalence and Determinants of Anxiety and Depression Symptoms in Patients with Type 2 Diabetes in Lithuania. Medical Science Monitor, 20, 182-190.
[14]  Pouwer, F. and Hermanns, N. (2009) Insulin Therapy and Quality of Life. A Review. Diabetes/Metabolism Research and Reviews, 25, S4-S10.
[15]  Stratégie Nationale Multisectorielle de Prévention et de Contrôle des Maladies Non Transmissibles 2019-2029.
[16]  Zigmond, A.S. and Snaith, R.P. (1983) The Hospital Anxiety and Depression Scale. Acta Psychiatrica Scandinavica, 67, 361-370.
[17]  Obtel, M., El Rhazi, K., Elhold, S., Benjelloune, M., Gnatiuc, L. and Nejjari, C. (2013) Cross-Cultural Adaptation of the 12-Item Short-Form Survey Instrument in a Moroccan Representative Survey. Southern African Journal of Epidemiology and Infection, 28, 166-171.
[18]  Ware, J.E., Kosinski, M. and Keller, S.D. (1996) A 12-Item Short-Form Health Survey: Construction of Scales and Preliminary Tests of Reliability and Validity. Medical Care, 34, 220-233.
[19]  Bensbaa, S., Agerd, L., Boujraf, S., et al. (2014) Clinical Assessment of Depression and Type 2 Diabetes in Morocco: Economical and Social Components. Journal of Neurosciences in Rural Practice, 5, 250-253.
[20]  Polonsky, W.H., Hajos, T.R.S., Dain, M.-P. and Snoek, F.J. (2011) Are Patients with Type 2 Diabetes Reluctant to Start Insulin Therapy? An Examination of the Scope and Underpinnings of Psychological Insulin Resistance in a Large, International Population. Current Medical Research and Opinion, 27, 1169-1174.
[21]  Réticences à l’insulinothérapie du patient diabétique de type 2: Croyances du soigné et du soignant.
[22]  Skinner, T.C., Carey, M.E., Cradock, S., et al. (2010) Depressive Symptoms in the First Year from Diagnosis of Type 2 Diabetes: Results from the Desmond Trial. Diabetic Medicine, 27, 965-967.
[23]  Palizgir, M., Bakhtiari, M. and Esteghamati, A. (2013) Association of Depression and Anxiety with Diabetes Mellitus Type 2 Concerning Some Sociological Factors. Iranian Red Crescent Medical Journal, 15, 644-648.
[24]  Trento, M., Raballo, M., Trevisan, M., et al. (2012) A Cross-Sectional Survey of Depression, Anxiety, and Cognitive Function in Patients with Type 2 Diabetes. Acta Diabetologica, 49, 199-203.
[25]  Reis, A.C., Cunha, M.V., Bianchin, M.A., Freitas, M.T.R., Castiglioni, L., et al. (2020) Comparison of Quality of Life and Functionality in Type 2 Diabetics with and without Insulin. Revista da Associacao Medica Brasileira, 65, 1464-1469.
[26]  Redekop, W.K., Koopmanschap, M.A., Stolk, R.P., et al. (2002) Health-Related Quality of Life and Treatment Satisfaction in Dutch Patients with Type 2 Diabetes. Diabetes Care, 25, 458-463.
[27]  Chantelau, E., Schiffers, T., Schütze, J. and Hansen, B. (1997) Effect of Patient-Selected Intensive Insulin Therapy on Quality of Life. Patient Education and Counseling, 30, 167-173.
[28]  Funnell, M.M. (2008) Quality of Life and Insulin Therapy in Type 2 Diabetes Mellitus. Insulin, 3, 31-36.
[29]  U.K. Prospective Diabetes Study Group (1999) Quality of Life in Type 2 Diabetic Patients Is Affected by Complications but Not by Intensive Policies to Improve Blood Glucose or Blood Pressure Control (UKPDS 37). Diabetes Care, 22, 1125-1136.


comments powered by Disqus

Contact Us


WhatsApp +8615387084133

WeChat 1538708413